Literature DB >> 8889436

Red blood cell aggregability is increased by aspirin and flow stress, whereas dipyridamole induces cell shape alterations: measurements by digital image analysis.

J Bozzo1, M R Hernández, A Del Giorgio, A Ordinas.   

Abstract

We evaluated the influence of pretreatment with aspirin in vitro, alone or combined with dipyridamole, on red cell aggregability. Samples were tested before and after being exposed to well-defined flow conditions. An aggregation rate was estimated through digital analysis of light microscopy images. Red cells of untreated blood that had been exposed to flow showed a higher aggregation rate (38.54 +/- 1.63 vs. 27.52 +/- 1.36; P < 0.05). This effect was not observed in the absence of platelets. Treatment with aspirin induced a high aggregation rate, with or without exposure to flow conditions. Dipyridamole alone or combined with aspirin provoked echinocytosis, disturbing the rouleaux arrangement (rates ranging from 11.25 +/- 1.91 - 13.62 +/- 1.62). Washing red cells after treatment restored about 90% of echinocytes to their biconcave shape, but aggregation rate did not recover in parallel. These results highlight the influence of red cell-platelet interactions in the regulation of haemostasis and show how therapeutic agents can interfere with rheological phenomena.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889436     DOI: 10.1046/j.1365-2362.1996.1960540.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  2 in total

1.  Quantitative Measurement and Evaluation of Red Blood Cell Aggregation in Normal Blood Based on a Modified Hanai Equation.

Authors:  Jianming Wen; Nen Wan; Huilu Bao; Jianping Li
Journal:  Sensors (Basel)       Date:  2019-03-04       Impact factor: 3.576

2.  Effects of aspirin on rheological properties of erythrocytes in vitro.

Authors:  Mohamed A Elblbesy; Abdel Rahman M Hereba; Mamdouh M Shawki
Journal:  Int J Biomed Sci       Date:  2012-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.